Dr. Lisa Nash, a TCOM graduate, will continue to lead the college toward excellence. Leadership at The University of North ...

Researchers identify the Asah1 gene as a promising target for novel therapies to treat nonalcoholic fatty liver disease ...

Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...

New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...

The approved fiscal year 2024 and 2025 budget for Bert Nash included $200,000 of support for the Assertive Community Treatment program. The county administration is allocating the funding from the ...

A team of experts from the Icahn School of Medicine at Mount Sinai has become the first in the United States to perform a ...

NAFLD, the most prevalent liver disease, affects approximately 25% of the global population (1.2 billion people), including 188 million in India. Left untreated, NAFLD can progress to non-alcoholic ...

A group of around half a dozen pharma companies are trying to develop treatment for NASH, for which there is no approved treatment. The market for NASH drugs is expected to exceed $1 billion soon ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Douglas County commissioners on Wednesday will consider approving a grant application that would help fund services for ...

The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...